Thomas William Burns, Chairman and Chief Executive Officer of Glaukos Corp (NYSE:GKOS), filed a Form 4 on November 20, 2026, disclosing the exercise of 180,000 stock options and the sale of 180,000 shares of common stock on November 18, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Option exercise: Burns exercised 180,000 stock options at an exercise price of $45.71 per share on November 18, 2026, reducing his direct option holdings to zero remaining options with a March 15, 2027 expiration date.
  • Shares sold: A total of 180,000 shares of common stock were sold across 15 separate transactions on November 18, 2026, at weighted average prices ranging from $232.61 to $245.90 per share.
  • 10b5-1 plan: According to the filing, the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Burns on August 20, 2026, with respect to options expiring on March 15, 2027.
  • Remaining direct holdings: Following all reported transactions, Burns directly held 65,060 shares of common stock, which the filing notes includes 48,673 restricted stock units that have not yet vested or been delivered.
  • Indirect holdings: Burns also holds shares indirectly through five trusts, totaling 1,699,700 shares: 1,141,593 through the Burns Family Trust, 238,107 through the Burns Annuity Trust, 120,000 through the Burns Charitable Remainder Trust, 100,000 through the Thomas W. Burns Irrevocable Trust, and 100,000 through the Janet M. Burns Irrevocable Trust.

Burns Exercises Expiring Options and Sells Shares Under Pre-Planned Trading Program

According to the Form 4 filing, Burns first exercised a stock option to acquire 180,000 shares of Glaukos common stock at $45.71 per share on November 18, 2026. The option, which carried an expiration date of March 15, 2027, was fully exercised, leaving zero derivative securities of this type remaining in his direct ownership, the filing disclosed.

Immediately following the exercise, the filing shows Burns disposed of all 180,000 acquired shares through 15 separate sales transactions, all executed on November 18, 2026. The weighted average prices for those transactions ranged from $232.61 on the first tranche of 40,450 shares to $245.90 on the final tranche of 234 shares. Each individual transaction was itself executed across multiple trades within defined price bands, and the filing states that Burns "undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected." The sales were conducted under a Rule 10b5-1 trading plan that Burns adopted on August 20, 2026.

After all transactions, Burns reported direct beneficial ownership of 65,060 shares, a figure the filing states includes 48,673 restricted stock units not yet vested or delivered. His substantial indirect ownership positions through five family and charitable trusts were unchanged by the reported transactions.

What Was Disclosed

The filing reports the November 18, 2026, exercise of 180,000 stock options at $45.71 and the same-day sale of 180,000 Glaukos common shares at weighted average prices from $232.61 to $245.90, all under a pre-adopted 10b5-1 plan, leaving Burns with 65,060 directly held shares.